These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17003936)

  • 21. [A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis].
    Nomura S; Kouzuma R; Komura T; Sadayasu T; Segawa J; Nakashima Y; Kuroiwa A
    Kokyu To Junkan; 1992 Mar; 40(3):299-302. PubMed ID: 1579754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination.
    Blaha M; Kostal M; Lanska M; Blaha V; Foralova I; Filip S; Kubisova M; Maly J
    Atheroscler Suppl; 2013 Jan; 14(1):77-81. PubMed ID: 23357146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between high sensitive C-reactive protein, lipoprotein(a), blood uric acid and severity of coronary artery disease].
    He P; Xie XH; Ding YP; Chen XL
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1989-91. PubMed ID: 20979866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
    Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small LDL and hsCRP as new risk factors for coronary artery disease.
    Brown CL; Garrett B; Superko HR
    J Med Assoc Ga; 2001 Dec; 90(4):11-6. PubMed ID: 11845678
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia.
    Sibley C; McGann S; Stone NJ
    Am J Cardiol; 2004 Sep; 94(5):699-700. PubMed ID: 15342318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis].
    Mellwig KP; Schmidt HK; Brettschneider-Meyer A; Meyer H; Jaeger BR; Walli AK; Seidel D; Horstkotte D
    Internist (Berl); 2003 Apr; 44(4):476-80. PubMed ID: 12914404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [LDL-apheresis].
    Makino H; Harada-Shiba M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():504-8. PubMed ID: 17824079
    [No Abstract]   [Full Text] [Related]  

  • 30. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators.
    Tatami R; Inoue N; Itoh H; Kishino B; Koga N; Nakashima Y; Nishide T; Okamura K; Saito Y; Teramoto T
    Atherosclerosis; 1992 Jul; 95(1):1-13. PubMed ID: 1642687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative ultrastructural study of platelet plasma-membrane in hypercholesterolemic type IIa patients after plasma exchange and LDL-apheresis.
    Bianciardi G; Gnasso A; Postiglione A; Scarpato N; Tanganelli P; Weber G
    Beitr Infusionsther; 1988; 23():183-8. PubMed ID: 2484775
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
    Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
    Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [LDL-apheresis therapy of hyperlipidemia].
    Lee YJ
    Nihon Rinsho; 1990 Nov; 48(11):2629-35. PubMed ID: 2270031
    [No Abstract]   [Full Text] [Related]  

  • 34. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermofiltration in hypercholesterolemia: analysis of removal and posttreatment cholesterol recovery.
    Malchesky PS; Nomura H; Werynski A; Takeyama Y; Yamashita M; Nosè Y
    Prog Clin Biol Res; 1990; 337():201-4. PubMed ID: 2352977
    [No Abstract]   [Full Text] [Related]  

  • 37. LDL-apheresis and improvement in the coronary atherosclerosis of familial hypercholesterolemia--correlation of computerized quantitative coronary angiography with autopsy findings.
    Koga N; Satoh T; Watanabe K; Kohchi K; Iwata Y; Minami H
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):37-52. PubMed ID: 1751679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment by LDL-apheresis during pregnancy].
    Schlienger JL; Brignon P; Grunenberger F
    Presse Med; 2003 Apr; 32(13 Pt 1):603. PubMed ID: 12718320
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of low-density lipoprotein cholesterol apheresis on blood viscosity.
    Moriarty PM; Gibson CA; Kensey KR; Hogenauer W
    Am J Cardiol; 2004 Apr; 93(8):1044-6. PubMed ID: 15081454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholesterolaemia.
    Blaha M; Pecka M; Urbankova J; Blaha V; Maly J; Zadak Z; Blazek M
    Transfus Apher Sci; 2004 Apr; 30(2):83-7. PubMed ID: 15062743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.